Bafna Pharmaceuticals Ltd.
Snapshot View

View in App

Prices View details >>

97.80 +1.00 ▲1.0%

03 February 2023, 04:01:00 PM
Volume: 202

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.bafnapharma.com
Market Cap 231.36 Cr.
Enterprise Value(EV) 251.35 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 1.55 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 63.25 Trailing Twelve Months Ending 2022-09
Industry PE 32.22 Trailing Twelve Months Ending 2022-09
Book Value / Share 27.83 Trailing Twelve Months Ending 2022-09
Price to Book Value 3.51 Calculated using Price: 97.80
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 2.37 Cr. 23,656,335 Shares
FaceValue 10
Company Profile
Bafna Pharmaceuticals was incepted by Bafna Mahaveer Chand in 1981 as a proprietary concern. It was converted into a public limited company on 28th march 1995. The company started its own manufacturing unit in October 1984.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.03%
1 Week
-3.17%
1 Month
-4.91%
3 Month
-6.81%
6 Month
-11.73%
1 Year
-34.34%
2 Year
-18.26%
5 Year
+320.65%
10 Year
+119.53%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 2.25 9.22 -18.69 -37.05 -40.37 -64.36 -22.93 22.26 8.61
Return on Capital Employed (%) 9.15 12.56 -0.04 -5.98 -6.97 -20.90 -2.95 10.62 8.39
Return on Assets (%) 0.57 2.99 -6.58 -10.49 -11.17 -15.90 -1.96 7.40 5.83

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 69 72 59 45 41 21 51 57 63 66
Non Curr. Liab. 27 14 39 42 28 29 3 5 11 7
Curr. Liab. 126 100 87 81 59 71 17 24 16 34
Minority Int.
Equity & Liab. 223 185 185 167 128 121 71 86 90 106
Non Curr. Assets 66 68 65 90 79 72 35 37 39 43
Curr. Assets 149 117 119 77 48 48 36 50 51 63
Misc. Exp. not W/O 8 1
Total Assets 223 185 185 167 128 121 71 86 90 106

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 178 143 85 65 47 44 42 71 85 74
Other Income 1 1 1 1 31 0 0 1 2 4
Total Income 179 144 87 66 78 44 43 72 87 78
Total Expenditure -156 -117 -83 -70 -82 -57 -41 -61 -74 -68
PBIDT 23 26 4 -4 -4 -13 1 11 14 10
Interest -12 -12 -12 -11 -7 -2 0 -1 -1 -1
Depreciation -8 -5 -4 -4 -4 -3 -3 -4 -5 -5
Taxation -1 0 0 1 -2 -2
Exceptional Items -3 -2 0
PAT 1 6 -12 -18 -16 -20 -2 6 5 4
Adjusted EPS 1 3 -7 -10 -7 -8 -8 2 2 2

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 35 1 9 -3 20 -7 -1 -34 -14 8
Cash Fr. Inv. -6 -5 56 -1 -14 38 4 33 -5 -5
Cash Fr. Finan. -11 -14 -66 4 -5 -31 -2 7 12 -4
Net Change 18 -18 0 0 0 0 6 -7 -2
Cash & Cash Eqvt 21 2 2 3 3 3 3 8 2 0

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 92.64 91.74 90.39 90.40 90.42 90.42 90.12 90.00 90.02
Public 7.36 8.26 9.61 9.60 9.58 9.58 9.88 10.00 9.98
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 1.45 1.47 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Wed, 01 Feb 2023
Board Meeting Intimation for Considering The Unaudited Results For The Nine Months Period And Quarter Ended 31.12.2022
BAFNA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2023 inter alia to consider and approve the Unaudited Results for the Nine Months Period and Quarter ended 31.12.2022
Fri, 20 Jan 2023
Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Bafna Pharmaceuticals Limited Awarded With MSME-ZED Certified GOLD CERTIFICATE
Bafna Pharmaceuticals Limited is proud to announce that the Company has been awarded MSME ZED GOLD CERTFICATE by the Ministry of Micro Small & Medium Enterprises Government of India.
Thu, 19 Jan 2023
Announcement under Regulation 30 (LODR)-Resignation of Director
Resignation of Mr. Atul Sachdeva as an Non Executive Non Independent Director of the Company with effect from 13th January 2023.

Technical Scans View Details >>

Fri, 03 Feb 2023
Opening at High Opening at High
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease in 1 Year High Decrease in 1 Year
High Increase in 5 Years High Increase in 5 Years
Thu, 02 Feb 2023
Higher Delivery Quantity Higher Delivery Quantity

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 246,567.66 1,027.65 +2.0%
Cipla Ltd. 82,812.97 1,026.00 +0.1%
Divi's Laboratories Ltd. 76,573.08 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. 72,577.66 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. 61,039.46 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. 52,289.82 1,545.00 +0.3%
Abbott India Ltd. 44,198.55 20,800.00 +1.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 58.54 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-12 31.39 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 25.59 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.92 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.70 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.92 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-09 50.12 20,800.00 +1.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.46 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-12 3.65 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 6.31 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.30 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.20 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.20 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-09 16.28 20,800.00 +1.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 0.00 20,800.00 +1.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 20,800.00 +1.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 20,800.00 +1.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,800.00 +1.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 798.70 20,800.00 +1.5%

FAQ's On Bafna Pharmaceuticals Ltd.

What is Bafna Pharma share price?
Can I buy Bafna Pharma shares now?
What is the Market Cap of Bafna Pharma?
What are the key metrics to analyse Bafna Pharma?
What is the 52 Week High and Low of Bafna Pharma?
What is the trend of Bafna Pharma share price?